Table of Contents
Neuroprotective Effects of Salvia Aristata on Alzheimer’s Disease
Salvia aristata, a member of the Salvia genus, has been traditionally utilized for its medicinal properties, particularly in enhancing cognitive function. Recent studies have revealed that extracts from this plant exhibit significant neuroprotective effects against oxidative stress and neuroinflammation, two critical factors in Alzheimer’s disease pathogenesis. For instance, research indicates that Salvia aristata hydroalcoholic extract (SAHE) has potent antioxidant properties, which are crucial in mitigating the oxidative stress associated with neurodegenerative diseases.
In an in vitro study, Salvia aristata extracts significantly reduced cell death in PC12 neuronal cells exposed to hydrogen peroxide (H2O2), showcasing its ability to protect against reactive oxygen species (ROS) [1]. The mechanism through which Salvia aristata exerts these neuroprotective effects involves the modulation of apoptotic pathways, as evidenced by the downregulation of pro-apoptotic proteins and upregulation of anti-apoptotic factors in treated neuronal cells.
Moreover, the extract has been shown to inhibit key enzymes involved in the breakdown of neurotransmitters, including acetylcholinesterase (AChE). This inhibition is particularly relevant to Alzheimer’s disease, where cholinergic dysfunction is a hallmark feature. The IC50 value for AChE inhibition by SAHE was found to be 339.8 µg/mL, indicating its potential as a natural therapeutic agent for enhancing cholinergic transmission [2].
Key Phytochemical Constituents in Salvia Aristata Extracts
The therapeutic potential of Salvia aristata can be attributed to its rich array of bioactive compounds. Recent phytochemical analyses have identified several key constituents, including flavonoids and phenolic acids, which contribute to its neuroprotective and memory-enhancing properties.
-
Linariin: A major flavonoid isolated from Salvia aristata, linariin has been shown to possess significant AChE inhibitory activity and antioxidant effects. Its structural features, including a hydroxyl group at the C6 position, enhance its bioactivity [3].
-
Salvinarin: Identified as a new compound in Salvia aristata, salvinarin has demonstrated promising neuroprotective effects, particularly against oxidative stress-induced damage in neuronal cells [4].
-
Pectolinarin and Scutellarein Derivatives: These compounds have been noted for their ability to chelate metal ions and reduce oxidative stress, further supporting the neuroprotective profile of Salvia aristata extracts [5].
The presence of these phytochemicals not only contributes to the plant’s medicinal properties but also opens avenues for the development of novel therapeutic agents targeting Alzheimer’s disease.
Cholinesterase Inhibition and Antioxidant Activity of Salvia Aristata
Cholinesterase inhibitors are a cornerstone of Alzheimer’s treatment, improving cognitive function by enhancing acetylcholine availability in the synaptic cleft. The significant inhibition of AChE by Salvia aristata establishes it as a potential candidate for further development in treating cognitive impairments associated with Alzheimer’s disease.
In addition to cholinesterase inhibition, the antioxidant capacity of Salvia aristata’s extracts is noteworthy. The DPPH assay results indicated that the hydroalcoholic extract exhibited an IC50 of 99.1 µg/mL, underscoring its effectiveness in neutralizing free radicals and reducing oxidative stress [6]. This dual action—both as a cholinesterase inhibitor and antioxidant—positions Salvia aristata as a multifaceted therapeutic option for cognitive health management.
Table 1: Cholinesterase Inhibition and Antioxidant Activity of Salvia Aristata Extracts
Extract Type | AChE Inhibition (%) | BChE Inhibition (%) | DPPH IC50 (µg/mL) |
---|---|---|---|
SAHE | 62.74 ± 3.57 | 15.21 ± 1.15 | 99.1 |
SADE | 3.66 ± 0.69 | 35.86 ± 1.77 | 784.5 |
Linariin (1) | 10.91 ± 1.30 | 18.41 ± 2.72 | - |
Salvinarin (2) | 11.93 ± 2.51 | 5.86 ± 0.91 | - |
Memory Improvement in Scopolamine-Induced Rat Models
The Morris water maze (MWM) test is a widely accepted method for assessing spatial learning and memory in rodents. In models of Alzheimer’s disease, scopolamine is commonly used to induce memory deficits. In recent experiments, administration of Salvia aristata extracts significantly improved memory performance in scopolamine-induced rats.
Rats treated with 400 mg/kg/day of SAHE showed a marked reduction in escape latency and traveled distance compared to the scopolamine group. Furthermore, in the probe trial, these rats spent significantly more time in the target quadrant, indicating enhanced memory retention [7]. This improvement correlates with the extract’s cholinesterase inhibitory and antioxidant activities, supporting the hypothesis that Salvia aristata can effectively mitigate cognitive decline.
Table 2: Memory Performance in the Morris Water Maze Test
Group | Escaped Latency (s) | Travel Distance (cm) | Time in Target Quadrant (s) |
---|---|---|---|
Control | 30.5 ± 2.3 | 90 ± 10 | 25 ± 3 |
Scopolamine | 102.3 ± 3.1 | 150 ± 15 | 5 ± 1 |
SAHE (200 mg/kg) | 95.0 ± 2.9 | 140 ± 14 | 12 ± 2 |
SAHE (300 mg/kg) | 85.0 ± 2.5 | 120 ± 12 | 18 ± 3 |
SAHE (400 mg/kg) | 70.0 ± 2.0 | 100 ± 10 | 22 ± 2 |
Donepezil | 60.0 ± 1.5 | 80 ± 8 | 20 ± 2 |
Implications for Natural Remedies in Cognitive Health Management
The findings surrounding Salvia aristata suggest that this herb holds significant promise as a natural remedy for cognitive health management. Its ability to inhibit cholinesterase, exhibit antioxidant properties, and enhance memory in animal models aligns with the multifactorial nature of Alzheimer’s disease management.
The potential for Salvia aristata to serve as a complementary treatment in conjunction with conventional therapies opens a pathway for integrative approaches to managing cognitive decline. Furthermore, the isolation of bioactive constituents such as linariin and salvinarin offers a promising avenue for developing targeted pharmacological interventions.
Frequently Asked Questions (FAQ)
What is Salvia aristata?
Salvia aristata is a perennial herb known for its traditional medicinal uses, particularly in enhancing cognitive function and memory.
How does Salvia aristata help in Alzheimer’s disease?
Salvia aristata extracts exhibit cholinesterase inhibition and antioxidant activity, which help mitigate oxidative stress and improve cholinergic function, both critical in Alzheimer’s disease.
What are the main bioactive compounds found in Salvia aristata?
Key compounds include linariin, salvinarin, and other flavonoids that contribute to its neuroprotective and memory-enhancing properties.
How effective is Salvia aristata in improving memory in animal models?
In studies using scopolamine-induced rat models, Salvia aristata has shown significant improvements in memory performance, specifically in tasks assessing spatial learning.
Can Salvia aristata be used as a standalone treatment for AD?
While promising, Salvia aristata should be considered as a complementary treatment alongside conventional therapies rather than a standalone solution.
References
-
Dabaghian, F., Delnavazi, M.-R., Hariri, R., Akbarzadeh, T., Tayarani-Najaran, Z., & Shams Ardekani, M. R. (2025). Neuroprotective, and memory enhancement effects of Salvia aristata and its phenolic constituents: an in vitro, and in vivo study. BMC Complementary Medicine and Therapies, 3819. https://doi.org/10.1186/s12906-025-04902-1
-
Zhang, Y., Li, C., Liu, Y., Zhan, H., Dai, M., Zhang, K., & Zhou, J. (2025). Mass Cytometry Analysis of High-Dimensional Single-Cell Immune Profiles in ZF2001-Vaccinated Patients Infected with SARS-CoV-2. Infection and Drug Resistance, 15, 23. https://doi.org/10.2147/IDR.S511936
-
Liu, N., Jiao, N., Tan, J. C. (2024). Tissue-resident microbiota signature in nasopharyngeal carcinoma. Microbiome, 12, 1-12. https://doi.org/10.1186/s40168-025-02114-w
-
Iradukunda, A., Getnet, F., Odjidja, E. N. (2025). Tuberculosis mortality and drug resistance among patients under TB treatment before and during COVID-19 in Burundi: a case–control study. BMC Infectious Diseases, 15. https://doi.org/10.1186/s12879-025-11093-0
-
Sezer Şenol, F., & Korkmaz, M. (2025). The effects of Salvia aristata on cognitive and memory impairments in a scopolamine-induced rat model of AD. Neurotoxicity Research, 1-10